Navigation Links
Efforts to Recruit, Retain and Research Nation's Social Workers Gain Bipartisan Support in Congress
Date:2/27/2008

Dr. Dorothy I. Height Joined U.S. Congressman Ed Towns Today to Seek Support for H.R. 5447, The Dorothy I. Height and Whitney M. Young, Jr. Social Work Reinvestment Act

WASHINGTON, Feb. 27 /PRNewswire-USNewswire/ -- Congress is being asked to help the nation's 600,000 professional social workers better serve families and communities in need. U.S. Representative Edolphus Towns (D-NY) has introduced a bill that will establish a Social Work Reinvestment Commission to study policy issues associated with recruitment, retention, research and reinvestment in the profession of social work, and will support replicable programs of excellence throughout the country.

Original cosponsors include Rep. Christopher Shays (R-CT), Rep. Susan Davis (D-CA), Rep. Ciro Rodriguez (D-TX), Rep. Barbara Lee (D-CA), Rep. Luis Gutierrez (D-IL), and Rep. Stephanie Tubbs Jones (D-OH).

The United States is experiencing unprecedented levels of human, social service and health care needs. These needs now transcend social and economic strata, affect the old and the young, and place tremendous burdens on those in the middle. As a result, millions of Americans, from all walks of life, are served daily by social workers.

However, competing policy priorities, fiscal constraints, significant educational debt, comparatively insufficient salaries, increased administrative burdens, and unsupportive work environments are just a few of the common obstacles encountered by professional social workers. These barriers impede the delivery of essential services, affect recruitment and retention in the profession, and compromise access to necessary care -- especially for the most vulnerable.

Social Work Reinvestment Commission

H.R. 5447 will create a commission to research social work's impact in practice areas such as aging, child welfare, military and veteran's affairs, mental and behavioral health and disability, criminal justice, and health. It w
'/>"/>

SOURCE National Association of Social Workers
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. New AHIP Report Takes a Ten Year Look at the Unintended Consequences of State Efforts to Change the Insurance Market
2. New Research From America On the Move Foundation Indicates American Weight Loss Efforts Stalling
3. The Prem Rawat Foundation Supports Disaster-Relief Efforts in Mozambique
4. PSI Brings its Pioneering Efforts to a Close
5. Disabilities Rising Among Workers; Need for Employer-Driven Disability Awareness, Support Efforts Also Increases
6. Sunrise Provides Status Report on Special Independent Committee Investigation; Provides Updates on Managements Internal Control Review Efforts and on Legal Proceedings
7. Missouri House Recognizes Extraordinary Efforts Supporting National Guard Families
8. National Award Recognizes Delmarva Foundation and CareFirst BlueCross BlueShield Quality Improvement Efforts
9. Congress Should Redouble Efforts to Increase Federal Cigarette Tax
10. Vendormate VISION 4.0(TM) Streamlines Healthcare Security and Compliance Efforts
11. Red Cross Receives $250,000 From Wal-Mart to Assist With Southern California Wildfire Relief Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 1Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 2Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 3Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 4Cumberland Pharmaceuticals and Phebra Pty Ltd Sign Exclusive Agreement for Commercialization of Caldolor 28R 29 in Australia and New Zealand 5840 5Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 1Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 2Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 3Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 4Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 5Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 6Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 7Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 8Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 9Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 10Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 11Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 12Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 13Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 14Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 15Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 16Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 17Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 18Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 19Reportlinker Adds Driving Successful Pharma Brands 3A Case Studies of Real Product Launches 5837 20Geneticists hunt for scleroderma triggers 60340 1Geneticists hunt for scleroderma triggers 60340 2